| Biological, clinical and population relevance of 95 loci for blood lipids TM Teslovich, K Musunuru, AV Smith, AC Edmondson, IM Stylianou, ... Nature 466 (7307), 707-713, 2010 | 4173 | 2010 |
| Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European … BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ... European heart journal 38 (32), 2459-2472, 2017 | 3822 | 2017 |
| Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of … BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ... European heart journal 34 (45), 3478-3490, 2013 | 3225 | 2013 |
| Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society consensus panel statement on assessment, aetiology and management ES Stroes, PD Thompson, A Corsini, GD Vladutiu, FJ Raal, KK Ray, ... European heart journal 36 (17), 1012-1022, 2015 | 1621 | 2015 |
| Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) SS Anand, S Yusuf, V Vuksan, S Devanesen, KK Teo, PA Montague, ... The lancet 356 (9226), 279-284, 2000 | 1378 | 2000 |
| Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European … J Boren, MJ Chapman, RM Krauss, CJ Packard, JF Bentzon, CJ Binder, ... European heart journal 41 (24), 2313-2330, 2020 | 1350 | 2020 |
| Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on … M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ... European heart journal 35 (32), 2146-2157, 2014 | 1192 | 2014 |
| 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult TJ Anderson, J Grégoire, RA Hegele, P Couture, GBJ Mancini, ... Canadian Journal of Cardiology 29 (2), 151-167, 2013 | 1130 | 2013 |
| 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult TJ Anderson, J Grégoire, GJ Pearson, AR Barry, P Couture, M Dawes, ... Canadian Journal of Cardiology 32 (11), 1263-1282, 2016 | 1103 | 2016 |
| 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult–2009 recommendations J Genest, R McPherson, J Frohlich, T Anderson, N Campbell, ... Canadian Journal of Cardiology 25 (10), 567-579, 2009 | 1068 | 2009 |
| Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment A Wiegman, SS Gidding, GF Watts, MJ Chapman, HN Ginsberg, M Cuchel, ... European heart journal 36 (36), 2425-2437, 2015 | 993 | 2015 |
| Hypertriglyceridemia: its etiology, effects and treatment G Yuan, KZ Al-Shali, RA Hegele Cmaj 176 (8), 1113-1120, 2007 | 871 | 2007 |
| Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study M Cuchel, EA Meagher, H du Toit Theron, DJ Blom, AD Marais, ... The Lancet 381 (9860), 40-46, 2013 | 857 | 2013 |
| Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy H Cao, RA Hegele Human molecular genetics 9 (1), 109-112, 2000 | 815 | 2000 |
| Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction R Do, NO Stitziel, HH Won, AB Jørgensen, S Duga, P Angelica Merlini, ... Nature 518 (7537), 102-106, 2015 | 785 | 2015 |
| Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children KA Nerenberg, KB Zarnke, AA Leung, K Dasgupta, S Butalia, K McBrien, ... Canadian Journal of Cardiology 34 (5), 506-525, 2018 | 751 | 2018 |
| Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins MI Mackness, B Mackness, PN Durrington, PW Connelly, RA Hegele Current opinion in lipidology 7 (2), 69-76, 1996 | 734 | 1996 |
| Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics RR Williams, SC Hunt, MC Schumacher, RA Hegele, MF Leppert, ... The American journal of cardiology 72 (2), 171-176, 1993 | 721 | 1993 |
| 2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults GJ Pearson, G Thanassoulis, TJ Anderson, AR Barry, P Couture, N Dayan, ... Canadian journal of cardiology 37 (8), 1129-1150, 2021 | 719 | 2021 |
| The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management RA Hegele, HN Ginsberg, MJ Chapman, BG Nordestgaard, ... The lancet Diabetes & endocrinology 2 (8), 655-666, 2014 | 701 | 2014 |
Murray W HuffProfessor of Medicine, Western Universityایمیل تأیید شده در uwo.ca